Professional Documents
Culture Documents
IQ4I Research & Consultancy Published A New Report On "PCR Global Market - Forecast To 2025"
IQ4I Research & Consultancy Published A New Report On "PCR Global Market - Forecast To 2025"
IQ4I Research & Consultancy Published A New Report On "PCR Global Market - Forecast To 2025"
–Forecast to 2025
IQ4I Research & Consultancy published a new report on “PCR Global Market –
Forecast To 2025” This report analyzes and studies the overall market, major Drivers &
Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the
World.
IQ4I’s Report Contains 162 market data tables and 115 figures spread through 532
pages and an exhaustive TOC on “Polymerase Chain Reaction Global Market”,
[Techniques (Standard PCR, Real Time PCR/qPCR, Reverse transcriptase PCR, Digital PCR,
Assembly PCR, Multiplex PCR, Hot Start PCR, Others), Products (Instruments, Reagents &
Consumables, Software and Services), Applications (Clinical diagnostics, Industry
applications, and Others), End-Users (Hospitals and Laboratories, Pharmaceuticals, CRO's
and Biotech companies, Academics, and Others), Regional (North America, Europe, APAC
and RoW)]
PCR is an enzymatic reaction process in which multiple copies of desired DNA sequence is obtained
in a short period of time. This technique involves three steps namely denaturation, annealing and
extension which are repeated at every cycle to obtain the required gene amplification. PCR
technology global market is rapidly advancing at a steady rate with major applications in clinical
diagnostics, industrial applications, and biomedical research. According to IQ4I Research analysis,
the PCR global market is expected to grow at a high single digit CAGR to reach $12,910.1 million by
2025.
The factors driving the growth of PCR market are increasing demand for early detection of chronic
diseases, increasing demand for genetic and molecular testing, high prevalence of infectious diseases,
expiry of PCR patents of major players, increased investments in the field of companion diagnostics
using PCR, increasing qPCR based food safety testing, technological advancements and growing
demand for rapid diagnostic tests. However, factors like high cost of commercial PCR assays in
clinical diagnostics, lack of awareness and requirement of skilled labor, development of alternate
technologies and stringent regulatory framework are hampering the market.
The PCR market is classified by techniques, products, application, end-users and geography. Among
PCR Techniques, RealTime/qPCR segment accounted for the largest revenue in 2019 and is expected
to grow at a high single digit CAGR from 2019 to 2025 due to its specificity, sensitivity, rapidity, cost
effectiveness, no requirement for post PCR processing and data processing, ability to quantify DNA
or RNA. The digital PCR segment is the fastest growing market in 2019 and is expected to grow at a
–Forecast to 2025
double digit CAGR from 2019 to 2025 due to its potential and substantial impact on research as well
as diagnostic applications like the detection and quantification of low-level pathogens, rare genetic
sequences, copy number variations, relative gene expression in single cells, development of personal
genomics by reducing the time and cost of many of the “next-generation sequencing” methods.
Droplet digital PCR is one of the new and alternative technologies for qPCR for the quantification of
DNA templates. The massive partitioning of the sample is the main aspect of this technology making
it unique from other PCR technologies.
The PCR global market by product is segmented into instruments, reagents and consumables and
software and services. Among the products, reagents and consumables segment accounted for largest
revenue in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025 due to high
consumption of reagents in various kinds of tests that require different types of reagents and the
expanding molecular diagnostic industry. Reagents and consumables include enzymes, dNTPs,
template DNA, primers and probes, buffers, master mixes, nuclease free water and others (tracking
dye and wax beads). Software in the PCR market comprises primer designers and sequence softwares,
PCR data analysis software, integrated software and others.
The PCR global market by application is segmented into clinical diagnostics, industrial applications
and others. Among the applications, industrial segment accounted for the largest revenue in 2019 and
is expected to grow at a mid single digit CAGR from 2019 to 2025 due to exploring many
environmental issues like water safety, bioremediation, biodegradation, development of disease-
resistant and high-yield varieties of plants and animals, production of therapeutic proteins and
production of human vaccines from transgenic plants. Industrial applications are divided into
agricultural biotechnology, environmental, applied testing, animal husbandry and biomedical
research. Applied testing includes forensic and food safety testing while biomedical research includes
DNA sequencing, genotyping, biomarker discovery, gene expression and genetic mapping, DNA
cloning and others. The clinical diagnosis segment is the fastest growing market in 2019 and is
expected to grow at a high single digit CAGR from 2019 to 2025 due to shift in the disease
management paradigm from a focus on treatment to a stronger focus on prevention through early
diagnosis, the high morbidity and mortality rate associated with infectious diseases and various
cancers, the growth of the biomarker market, the development in genomics and proteomics, and
precision medicine and the expanded availability of Point of Care (POC) testing.
The PCR global market by end-users is segmented into hospitals and laboratories, pharmaceuticals,
CRO’s and biotech companies, academics and others. Among PCR end-users, academics segment
accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from
–Forecast to 2025
2019 to 2025 as PCR has become an indispensable research tool in creation, detection and monitoring
of genetically modified organisms (GMOs), genetic engineering, gene modification, transgenics,
cloning, hybridisation, synthetic biology and directed evolution. The hospitals & laboratories segment
is the fastest growing market in 2019 and is expected to grow at a high single digit from 2019 to 2025
due to high infectious and chronic disease burden compounded by diagnostic challenges in developing
countries.
Geographically, PCR market is segmented into North America, Europe, Asia-Pacific and Rest of the
world regions. Among these North America accounted for the largest revenue in 2019 and is expected
to grow at a mid single digit CAGR from 2019 to 2025, due to its high healthcare expenses, research
and development expenditure, increasing awareness about medical care, increasing demand for
molecular diagnostic and genetic tools for effective management and prevention of highly prevalent
chronic non-communicable diseases and infectious diseases. APAC region is the fastest growing
market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2025 as the market
is driven by low manufacturing and labour costs, high unmet medicinal requirements in infectious and
chronic disease segment such as cancer and HIV diseases. India and China are expected to be future
investment destinations because of their large patient populace base and intact market, demand for
affordable, quick and accurate diagnostic tests in healthcare segments.
PCR manufacturers are keen on developing new technologies, with reliable features and high tech
software services to the PCR devices like multiplexing, advanced optical technology, precise
temperature control with thermal gradients with statistical analysis, facial authentication login, small
footprint (size of the PCR), traceability control of PCR, voice commands, and RFID reader with
remote access to monitor diagnostic and life science research. For instance, BJS Biotechnologies LTD
(U.K.) offers xxpress NGx qPCR system, which utilizes resistive heating technology and forced air
cooling to deliver rapid temperature cycles. Combining this technology with a unique, ultra-low
thermal mass consumable makes the xxpress NGx the world’s fastest and most thermally uniform
qPCR thermal cycler as 40 cycles of qPCR is possible in 10 minutes. In April 2019, Thermo Fisher
Scientific launched the Applied Biosystems QuantStudio 6 and 7 Pro Real-Time PCR Systems, the
world’s first Smart qPCR instruments with features like facial authentication, voice commands, radio-
frequency identification (RFID)-enabled plate scanning, and quick access to service and support with
a single touch.
The major players in the global PCR market include Thermo Fisher Scientific, Inc (U.S.), Abbott
Laboratories, Inc. (U.S.), Hoffman La Roche (Switzerland), Agilent Technologies (U.S.), Qiagen
N.V. (Netherlands), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE
–Forecast to 2025
Healthcare (U.K.), Promega Corporation (U.S.), Merck KGaA (Germany), Takara Bio, Inc (Japan)
and BioMerieux SA (France).
The PCR global market is expected to grow at a CAGR of 6.9% from 2019 to 2025 to
reach $12,910.1 million by 2025.
Analysis of the global market by identifying various sub-segments of the PCR global
market.
Revenue forecast of the PCR market and strategic analysis of each submarket with
respect to individual growth trends.
Revenue forecast of the PCR market with respect to North America, Europe, Asia-
Pacific and the Rest of the World (RoW) regions.
Identification of the major market trends and factors driving or inhibiting the growth of
global PCR devices and its various sub-markets.
Analysis of the market share, regulatory scenario, patent trends, funding scenario,
refurbished devices, porters five force’s model and supply chain of the PCR market.
Major players’ profiles in PCR market and analysis of their business strategies and
market shares.
–Forecast to 2025
FIGURE 1
Others